Xinyi Chen Selected Research

n-pentanoic acid (valeric acid)

1/2021	Valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications.
12/2020	Valeric Acid Suppresses Liver Cancer Development by Acting as a Novel HDAC Inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xinyi Chen Research Topics

Disease

33	Neoplasms (Cancer) 03/2022 - 04/2003
12	Cataract (Cataracts) 02/2022 - 01/2016
7	Inflammation (Inflammations) 01/2022 - 01/2014
7	Infections 01/2022 - 01/2020
5	Breast Neoplasms (Breast Cancer) 01/2021 - 10/2011
4	Rupture 01/2022 - 01/2017
4	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 04/2021 - 09/2016
3	Hemorrhage 04/2021 - 06/2018
3	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2021 - 01/2020
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2020
3	Bullous Pemphigoid (Pemphigoid) 01/2021 - 01/2020
3	Hepatocellular Carcinoma (Hepatoma) 11/2020 - 12/2018
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 07/2015
3	Myocardial Infarction 01/2014 - 10/2006
2	Sepsis (Septicemia) 01/2022 - 01/2021
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 02/2021
2	COVID-19 01/2022 - 01/2020
2	Glioma (Gliomas) 01/2022 - 01/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 06/2019
2	Liver Neoplasms (Liver Cancer) 12/2020 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 06/2015
2	Thrombocytopenia (Thrombopenia) 06/2019 - 08/2018
2	Body Weight (Weight, Body) 01/2019 - 10/2006
2	Carcinoma (Carcinomatosis) 05/2017 - 05/2012
2	Astigmatism 01/2017 - 01/2016
2	Endophthalmitis (Ophthalmia) 01/2017 - 01/2017
1	Dyslipidemias (Dyslipidemia) 06/2022
1	Hypertension (High Blood Pressure) 06/2022
1	Critical Illness (Critically Ill) 03/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Pseudomonas Infections 01/2022
1	Endotoxemia 01/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Pathologic Processes 01/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Trachoma 01/2022
1	Vesicular Stomatitis 01/2022

Drug/Important Bio-Agent (IBA)

8	Pharmaceutical PreparationsIBA 01/2022 - 01/2015
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2019
5	Therapeutic UsesIBA 01/2021 - 10/2011
4	Inosine Triphosphate (ITP)IBA 04/2021 - 09/2016
4	CytokinesIBA 01/2021 - 04/2019
3	Capsules (Microcapsules)IBA 02/2022 - 01/2017
3	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2017
3	Biological ProductsIBA 01/2021 - 06/2015
2	TeaIBA 06/2022 - 05/2012
2	AntibodiesIBA 01/2022 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2017
2	MicroRNAs (MicroRNA)IBA 01/2022 - 07/2013
2	LigandsIBA 01/2022 - 01/2016
2	Valeriana extractIBA 01/2021 - 12/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2021
2	Toll-Like Receptor 4IBA 01/2021 - 01/2019
2	AcidsIBA 01/2021 - 12/2020
2	Caspase 3 (Caspase-3)IBA 01/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2020
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2021 - 08/2020
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 01/2015
2	n-pentanoic acid (valeric acid)IBA 01/2021 - 12/2020
2	CateninsIBA 01/2021 - 10/2011
2	Histone Deacetylase InhibitorsIBA 01/2021 - 12/2020
2	Indomethacin (Indometacin)FDA LinkGeneric 09/2020 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 10/2006
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020 - 10/2006
2	Peptides (Polypeptides)IBA 01/2014 - 01/2013
1	CollagenIBA 06/2022
1	Histone-Lysine N-MethyltransferaseIBA 03/2022
1	nintedanibIBA 01/2022
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2022
1	Metalloproteases (Metalloproteinases)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Y 27632IBA 01/2022
1	AldehydesIBA 01/2022
1	ceftazidime drug combination avibactamIBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	5,7- dihydroxy- 6- methoxy- 2- phenylchromen- 4- oneIBA 01/2022
1	DisintegrinsIBA 01/2022
1	Chemokine CXCL10IBA 01/2022
1	diethyl succinateIBA 01/2022
1	Acrolein (Aqualin)IBA 01/2022
1	fasudil (AT 877)IBA 01/2022
1	NucleotidesIBA 01/2022
1	Ornithine Carbamoyltransferase (Ornithine Transcarbamylase)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2022
1	Succinic Acid (Succinate)IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	InterferonsIBA 01/2022
1	Lipid NanoparticlesIBA 01/2022

Therapy/Procedure

10	Therapeutics 01/2022 - 01/2019
6	Phacoemulsification 01/2019 - 01/2016
5	Lasers (Laser) 02/2022 - 01/2016
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 09/2020 - 06/2018
3	Drug Therapy (Chemotherapy) 06/2019 - 10/2016
2	Intraocular Lenses (Intraocular Lens) 01/2022 - 01/2019
2	Capsulorhexis 01/2019 - 01/2016
1	Critical Care (Surgical Intensive Care) 03/2022